title: Simultaneous steroids/interferon therapy in chronic hepatitis B.
authors.forename: X
authors.initials: X
authors.lastname: Causse
authors.forename: H
authors.initials: H
authors.lastname: Godinot
authors.forename: M
authors.initials: M
authors.lastname: Chevallier
authors.forename: P
authors.initials: P
authors.lastname: Chossegros
authors.forename: F
authors.initials: F
authors.lastname: Zoulim
authors.forename: J P
authors.initials: JP
authors.lastname: Zarski
authors.forename: C
authors.initials: C
authors.lastname: Meschiewitz
authors.forename: J
authors.initials: J
authors.lastname: Albrecht
authors.forename: C
authors.initials: C
authors.lastname: Trépo
mesh_terms: D000328:Adult; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004279:DNA, Viral / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000097:blood / Q000628:therapy*; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011241:Prednisone